461 related articles for article (PubMed ID: 17683362)
21. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
[TBL] [Abstract][Full Text] [Related]
22. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic thrombocytopenic purpura in children.
Loirat C; Coppo P; Veyradier A
Curr Opin Pediatr; 2013 Apr; 25(2):216-24. PubMed ID: 23422353
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
25. Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura.
Barrows BD; Teruya J
Arch Pathol Lab Med; 2014 Apr; 138(4):546-9. PubMed ID: 24678685
[TBL] [Abstract][Full Text] [Related]
26. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
[TBL] [Abstract][Full Text] [Related]
27. Thrombotic thrombocytopenic purpura and adult onset Still's disease.
Gopal M; Cohn CD; McEntire MR; Alperin JB
Am J Med Sci; 2009 May; 337(5):373-6. PubMed ID: 19322066
[TBL] [Abstract][Full Text] [Related]
28. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
Coppo P; Froissart A;
Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
[TBL] [Abstract][Full Text] [Related]
30. How we approach an acquired thrombotic thrombocytopenic purpura patient.
Raval JS; Mazepa MA; Brecher ME; Park YA
Transfusion; 2014 Oct; 54(10):2375-82. PubMed ID: 25070750
[TBL] [Abstract][Full Text] [Related]
31. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
van Balen T; Schreuder MF; de Jong H; van de Kar NC
Eur J Haematol; 2014 Jan; 92(1):80-2. PubMed ID: 24118335
[TBL] [Abstract][Full Text] [Related]
32. Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.
Yates S; Matevosyan K; Rutherford C; Shen YM; Sarode R
Transfusion; 2014 Aug; 54(8):2064-7. PubMed ID: 24655327
[TBL] [Abstract][Full Text] [Related]
33. TTP and ADAMTS13: When Is Testing Appropriate?
Mannucci PM; Peyvandi F
Hematology Am Soc Hematol Educ Program; 2007; ():121-6. PubMed ID: 18024619
[TBL] [Abstract][Full Text] [Related]
34. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
Yomtovian R; Niklinski W; Silver B; Sarode R; Tsai HM
Br J Haematol; 2004 Mar; 124(6):787-95. PubMed ID: 15009067
[TBL] [Abstract][Full Text] [Related]
35. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
[TBL] [Abstract][Full Text] [Related]
36. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
Goyal J; Adamski J; Lima JL; Marques MB
J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472
[TBL] [Abstract][Full Text] [Related]
37. Treatment of thrombotic thrombocytopenic purpura.
Fontana S; Kremer Hovinga JA; Lämmle B; Mansouri Taleghani B
Vox Sang; 2006 May; 90(4):245-54. PubMed ID: 16635066
[TBL] [Abstract][Full Text] [Related]
38. Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature.
Ziman A; Mitri M; Klapper E; Pepkowitz SH; Goldfinger D
Transfusion; 2005 Jan; 45(1):41-9. PubMed ID: 15647017
[TBL] [Abstract][Full Text] [Related]
39. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.
Zheng XL; Kaufman RM; Goodnough LT; Sadler JE
Blood; 2004 Jun; 103(11):4043-9. PubMed ID: 14982878
[TBL] [Abstract][Full Text] [Related]
40. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
Connell NT; Cheves T; Sweeney JD
Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
